CPRX
Price
$20.29
Change
+$0.49 (+2.47%)
Updated
Sep 5 closing price
Capitalization
2.48B
60 days until earnings call
KNSA
Price
$35.71
Change
+$0.20 (+0.56%)
Updated
Sep 5 closing price
Capitalization
2.65B
59 days until earnings call
Interact to see
Advertisement

CPRX vs KNSA

Header iconCPRX vs KNSA Comparison
Open Charts CPRX vs KNSABanner chart's image
Catalyst Pharmaceuticals
Price$20.29
Change+$0.49 (+2.47%)
Volume$2.48M
Capitalization2.48B
Kiniksa Pharmaceuticals International
Price$35.71
Change+$0.20 (+0.56%)
Volume$328.3K
Capitalization2.65B
CPRX vs KNSA Comparison Chart in %
Loading...
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPRX vs. KNSA commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPRX is a Buy and KNSA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CPRX: $20.29 vs. KNSA: $35.71)
Brand notoriety: CPRX and KNSA are both not notable
CPRX represents the Biotechnology, while KNSA is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CPRX: 173% vs. KNSA: 56%
Market capitalization -- CPRX: $2.48B vs. KNSA: $2.65B
CPRX [@Biotechnology] is valued at $2.48B. KNSA’s [@Pharmaceuticals: Generic] market capitalization is $2.65B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPRX’s FA Score shows that 1 FA rating(s) are green whileKNSA’s FA Score has 1 green FA rating(s).

  • CPRX’s FA Score: 1 green, 4 red.
  • KNSA’s FA Score: 1 green, 4 red.
According to our system of comparison, both CPRX and KNSA are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPRX’s TA Score shows that 4 TA indicator(s) are bullish while KNSA’s TA Score has 3 bullish TA indicator(s).

  • CPRX’s TA Score: 4 bullish, 3 bearish.
  • KNSA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CPRX is a better buy in the short-term than KNSA.

Price Growth

CPRX (@Biotechnology) experienced а -1.46% price change this week, while KNSA (@Pharmaceuticals: Generic) price change was +6.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

CPRX is expected to report earnings on Nov 05, 2025.

KNSA is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNSA($2.65B) has a higher market cap than CPRX($2.48B). KNSA has higher P/E ratio than CPRX: KNSA (714.20) vs CPRX (12.30). KNSA YTD gains are higher at: 80.536 vs. CPRX (-2.779). CPRX has higher annual earnings (EBITDA): 281M vs. KNSA (5.98M). CPRX has more cash in the bank: 653M vs. KNSA (308M). CPRX has less debt than KNSA: CPRX (2.99M) vs KNSA (9.77M). CPRX has higher revenues than KNSA: CPRX (558M) vs KNSA (529M).
CPRXKNSACPRX / KNSA
Capitalization2.48B2.65B94%
EBITDA281M5.98M4,701%
Gain YTD-2.77980.536-3%
P/E Ratio12.30714.202%
Revenue558M529M105%
Total Cash653M308M212%
Total Debt2.99M9.77M31%
FUNDAMENTALS RATINGS
CPRX vs KNSA: Fundamental Ratings
CPRX
KNSA
OUTLOOK RATING
1..100
1024
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
97
Overvalued
PROFIT vs RISK RATING
1..100
2745
SMR RATING
1..100
3491
PRICE GROWTH RATING
1..100
8240
P/E GROWTH RATING
1..100
9732
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CPRX's Valuation (50) in the Pharmaceuticals Other industry is somewhat better than the same rating for KNSA (97) in the Pharmaceuticals Major industry. This means that CPRX’s stock grew somewhat faster than KNSA’s over the last 12 months.

CPRX's Profit vs Risk Rating (27) in the Pharmaceuticals Other industry is in the same range as KNSA (45) in the Pharmaceuticals Major industry. This means that CPRX’s stock grew similarly to KNSA’s over the last 12 months.

CPRX's SMR Rating (34) in the Pharmaceuticals Other industry is somewhat better than the same rating for KNSA (91) in the Pharmaceuticals Major industry. This means that CPRX’s stock grew somewhat faster than KNSA’s over the last 12 months.

KNSA's Price Growth Rating (40) in the Pharmaceuticals Major industry is somewhat better than the same rating for CPRX (82) in the Pharmaceuticals Other industry. This means that KNSA’s stock grew somewhat faster than CPRX’s over the last 12 months.

KNSA's P/E Growth Rating (32) in the Pharmaceuticals Major industry is somewhat better than the same rating for CPRX (97) in the Pharmaceuticals Other industry. This means that KNSA’s stock grew somewhat faster than CPRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPRXKNSA
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
72%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 9 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGIBX40.840.21
+0.52%
MFS International Intrinsic Value B
PHSKX60.470.12
+0.20%
Virtus KAR Mid-Cap Growth A
LGMAX26.180.03
+0.11%
Loomis Sayles Global Allocation A
JOPSX14.16N/A
N/A
JOHCM International Opps Institutional
PFPGX29.23N/A
N/A
Parnassus Growth Equity Institutional

CPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CPRX has been loosely correlated with SANA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CPRX jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPRX
1D Price
Change %
CPRX100%
+2.47%
SANA - CPRX
47%
Loosely correlated
-0.67%
LGND - CPRX
46%
Loosely correlated
-0.59%
VIR - CPRX
46%
Loosely correlated
+2.53%
SYRE - CPRX
43%
Loosely correlated
+0.06%
CRNX - CPRX
43%
Loosely correlated
+3.97%
More

KNSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with COYA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then COYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+0.56%
COYA - KNSA
39%
Loosely correlated
-1.72%
JBIO - KNSA
37%
Loosely correlated
-0.13%
SNDX - KNSA
36%
Loosely correlated
+5.25%
CPRX - KNSA
35%
Loosely correlated
+2.47%
ATXS - KNSA
35%
Loosely correlated
+7.43%
More